Characteristics and outcomes of methicillin-resistant staphylococcus aureus surgical-site infections in patients with cancer: A case-control study

Annals of Surgical Oncology

Volumn 17, Issue 6, 2010, Pages 1499-1506

  Chemaly, Roy F ^a   Hachem, Ray Y ^a   Husni, Rola N ^a,d   Bahna, Boulos ^a   Rjaili, Georges Abou ^b   Waked, Alain ^a   Graviss, Linda ^a   Bekele, B Nebiyou ^a   Shah, Jharna N ^a,c   Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d RIZK HOSPITAL   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RISK FACTOR; SARCOMA; SKIN CANCER; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL WOUND; UROGENITAL TRACT CANCER; WOUND DRAINAGE;

EID: 77954819275     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0923-5     Document Type: Article

References (40)

1. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26(2): 166-174
2. Reed SD, Friedman JY, Engemann JJ et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005;26(2):175-183
3. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother. 2009;64(Suppl 1):i3-10. Review.
4. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R; National Nosocomial Infections Surveillance System. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006;42:389-391
5. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention Guidelines for Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006. Available: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline 2006.pdf. Accessed June 2009.
6. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992;13(10):582-586
7. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178-182
8. Hidron AI, Kourbatova EV, Halvosa JS et al. Risk factors for colonization with (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 2005 Jul 15;41(2):159-166
9. Saner FH, Canbay A, Gerken G, Broelsch CE. Collateral damage of cephalosporins and quinolones and possibilities for control. Med Klin (Munich). 2009 Feb 15;104(2):114-118
10. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillinsusceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910-917
11. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-1444
12. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41(Suppl 4):S269-72.
13. Fierobe L, Decré D, Mùller C, Lucet JC, Marmuse JP, Mantz J, Desmonts JM. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. Clin Infect Dis. 1999;29:1231-1238
14. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003;9(11):1415-1422
15. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis. 2005;52(2):113-122
16. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med. 2002;162(19):2229-2235
17. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillinresistant and methicillin- susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28(3):273-279
18. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis. 1998;27:543-550
19. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 1995;31(1):13-24.
20. Milstone AM, Perl TM. Fact, fiction, or no data: what does surveillance for methicillin-resistant Staphylococcus aureus prevent in the intensive care unit? Clin Infect Dis. 2008;46: 1726-1728
21. Shukla S, Nixon M, Acharya M, Korim MT, Pandey R. Incidence of MRSA surgical-site infection in MRSA carriers in an orthopaedic trauma unit. J Bone Joint Surg Br. 2009;91(2): 225-228
22. Anderson DJ, Chen LF, Schmader KE, et al. Poor functional status as a risk factor for surgical site infection due to methicillinresistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2008;29:832-839
23. Yamamoto S, Fujita S, Akasu T, Ishiguro S, Kobayashi Y, Moriya Y. Wound infection after elective laparoscopic surgery for colorectal carcinoma. Surg Endosc. 2007;21(12): 2248-2252
24. Smith RL, Bohl JK, McElearney ST, Friel CM, Barclay MM, Sawyer RG, et al. Wound infection after elective colorectal resection. Ann Surg. 2004;239(5):599-605; discussion 605-607
25. Horzic M, Kopljar M. Postoperative infections in colorectal cancer patients. Hepatogastroenterology. 2005;52(61):101-104
26. Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208(1):53-61.
27. Demura S, Kawahara N, Murakami H et al. Surgical site infection in spinal metastasis: risk factors and countermeasures. Spine (Phila Pa 1976). 2009 Mar 15;34(6):635-639
28. Ishibashi K, Kuwabara K, Ishiguro T, et al. Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: results of a prospective randomized trial. Surg Today. 2009; 39(12):1032-1039
29. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20(4):250-78; quiz 279-280
30. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606-608
31. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584-599
32. Taconelli E. Antimicrobial use: risk driver of multidrug-resistant microorganisms in healthcare settings. Curr Opin Infect Dis. 2009;22:352-358
33. Cowie SE, Ma I, Lee SK, Smith RM, Hsiang YN. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome. Vasc Endovasc Surg. 2005;39(4):327-334
34. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36(5):592-598
35. Ferrante M, D'Hoore A, Vermeire S, et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis. 2009;15(7):1062-1070
36. Aldulaymi BH, Mohammad WA, Jess P. Perineal wound complications following preoperative radiotherapy for rectal cancer. Ugeskr Laeger. 2008;170(15):1225-1227
37. Li Q, Li H, Qin Y, Wang PP, Hao X. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience. J Gastroenterol Hepatol. 2007;22(11):1936-1941
38. El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245(5):665-671
39. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis. 2001;32:877-883
40. Malde DJ, Abidia A, McCollum C, Welch M. The success of routine MRSA screening in vascular surgery: a nine-year review. Int Angiol. 2006;25(2):204-208